Miller, Scott C., PhD

Chief, Division of Radiobiology

Research Interests

  • Radiobiology
  • Bone Biology

Languages

  • English

Academic Information

  • Departments: Nutrition and Integrative Physiology - Adjunct Professor, Radiology and Imaging Sciences - Research Professor
  • Divisions: Radiobiology

Academic Office Information

  • 801-581-5638
  • Imaging & Neurosciences Center
    729 Arapeen Dr, Room: 2334
    Salt Lake City, UT 84108

Education History

Type School Degree
Postdoctoral Fellowship Harvard University
Cell Biology
Postdoctoral Fellow
Doctoral Training University of Utah
Anatomy
Ph.D.
Undergraduate University of Utah
B.S.

Selected Publications

Journal Article

  1. Sokolova AB, Suslova KG, Khokhryakov VF, Khokhryakov VV, Vvendensky VE, Miller SC (). Development of an inhalation model for 241Am based on Mayak Production Association worker data. Health Phys, 105, 21-30.
  2. Chen H, Miller S, Lane RH, Moyer-Mileur LJ (). Intrauterine growth restriction decreases endochondral ossification and bone strength in female rats. Am J Perinatol, 30, 261-266.
  3. Suslova KG, Sokolova AB, Efimov AV, Miller SC (2013 Mar). Accumulation, organ distribution, and excretion kinetics of (2)(4)(1)Am in Mayak Production Association workers. Health Phys, 104(3), 313-24.
  4. Pan H, Sima M, Miller SC, Kopeckova P, Yang J, Kopecek J (2013 Sep). Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats. Biomaterials, 34(27), 6528-38.
  5. Khokhryakov VV, Khokhryakov VF, Suslova KG, Vostrotin VV, Vvedensky VE, Sokolova AB, Krahenbuhl MP, Birchall A, Miller SC, Schadilov AE, Ephimov AV (2013 Apr). Mayak Worker Dosimetry System 2008 (MWDS-2008): assessment of internal dose from measurement results of plutonium activity in urine. Health Phys, 104(4), 366-78.
  6. Suslova KG, Sokolova AB, Khokhryakov VV, Miller SC (2012 Mar). 238Pu: accumulation, tissue distribution, and excretion in Mayak workers after exposure to plutonium aerosols. Health Phys, 102(3), 243-50.
  7. Haley S, OGrady S, Gulliver K, Bowman B, Galdassarre R, Miller S, Lane RH, Moyer-Mileur LJ (). Mechanical-tactile stimulation (MTS) intervention in a neonatal stress model improves long-term outcomes in bone. J Musculoskelet Neuronal Interact, 11, 234-242.
  8. Miller SC, Wang X, Bowman BM (2010 Sep). Pharmacological properties of orally available, amphipathic polyaminocarboxylic acid chelators for actinide decorporation. Health Phys, 99(3), 408-12.
  9. Malik AK, Khaldoyanidi S, Auci DL, Miller SC, Ahlem CN, Reading CL, Page T, Frincke JM (2010). 5-Androstene-3beta,7beta,17beta-triol (beta-AET) slows thermal injury induced osteopenia in mice: relation to aging and osteoporosis. PLoS ONE, 5(10), e13566.
  10. Lyovkina YV, Miller SC, Romanov SA, Krahenbuhl MP, Belosokhov MV (2010 Oct). Quantitative plutonium microdistribution in bone tissue of vertebra from a Mayak worker. Health Phys, 99(4), 464-70.
  11. Chen H, Miller S, Shaw J, Moyer-Mileur L (). Massage therapy during early postnatal life promotes greater lean mass and bone growth, mineralization, and strength in juvenile and young adult rats. J Musculoskelet Neuronal Interact, 9, 278-287.
  12. Suslova KG, Sokolova AB, Krahenbuhl MP, Miller SC (2009 Mar). The effects of smoking and lung health on the organ retention of different plutonium compounds in the Mayak PA workers. Radiat Res, 171(3), 302-9.
  13. Levkina EV, Romanov SA, Miller SC, Krahenbuhl MP, Belosokhov MV (). Quantitative plutonium microdistribution in bone tissue of vertebra from occupationally exposed worker (in Russian). Radiats Biol Radioecol, 48(1), 356-363.
  14. Liu G, Men P, Kenner GH, Miller SC (2008). Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Hemoglobin, 32(1-2), 181-90.
  15. Matsushita H, Barrios JA, Shea JE, Miller SC (2008). Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab, 26(3), 241-7.
  16. Pan H, Sima M, Kopeckova P, Wu K, Gao S, Liu J, Wang D, Miller SC, Kopecek J (2008 Jul-Aug). Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates. Mol Pharm, 5(4), 548-58.
  17. Miller SC, Pan H, Wang D, Bowman BM, Kopeckova P, Kopecek J (2008 Dec). Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats. Pharm Res, 25(12), 2889-95.
  18. Vasilenko EK, Khokhryakov VF, Miller SC, Fix JJ, Eckerman K, Choe DO, Gorelov M, Khokhryakov VV, Knyasev V, Krahenbuhl MP, Scherpelz RI, Smetanin M, Suslova K, Vostrotin V (2007 Sep). Mayak worker dosimetry study: an overview. Health Phys, 93(3), 190-206.
  19. Bess JD, Krahenbuhl MP, Miller SC, Slaughter DM, Khokhryakov VV, Khokhryakov VF, Suslova KG, Vostrotin VV (2007 Sep). Uncertainties analysis for the plutonium dosimetry model, doses-2005, using Mayak bioassay data. Health Phys, 93(3), 207-19.
  20. Wang D, Miller SC, Shlyakhtenko LS, Portillo AM, Liu XM, Papangkorn K, Kopeckova P, Lyubchenko Y, Higuchi WI, Kopecek J (2007 Sep-Oct). Osteotropic Peptide that differentiates functional domains of the skeleton. Bioconjug Chem, 18(5), 1375-8.
  21. Pan H, Kopeckova P, Liu J, Wang D, Miller SC, Kopecek J (2007 Dec). Stability in plasmas of various species of HPMA copolymer-PGE1 conjugates. Pharm Res, 24(12), 2270-80.
  22. Romanov SA, Guilmette RA, Khokhryakov VF, Phipps A, Aladova EE, Bertelli L, Birchall A, Eckerman KF, Khokhryakov VV, Krahenbuhl MP, Leggett RW, Little TT, Miller G, Miller SC, Riddell A, Suslova KG, Vostrotin VV, Zaytseva YV (2007). Comparison of dose estimation from occupational exposure to 239Pu using different modelling approaches. Radiat Prot Dosimetry, 127(1-4), 486-90.
  23. Wang D, Miller SC, Liu XM, Anderson B, Wang XS, Goldring SR (2007). Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res Ther, 9(1), R2.
  24. Miller SC, Bowman BM (2007 Jan). Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation. Anat Rec (Hoboken), 290(1), 65-73.
  25. Miller SC, Liu G, Bruenger FW, Lloyd RD (2006). Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat. Radiat Prot Dosimetry, 118(4), 412-20.
  26. Suslova KG, Khokhryakov VF, Tokarskaya ZB, Nifatov AP, Sokolova AB, Miller SC, Krahenbuhl MP (2006 Apr). Modifying effects of health status, physiological, and dosimetric factors on extrapulmonary organ distribution and excretion of inhaled plutonium in workers at the Mayak Production Association. Health Phys, 90(4), 299-311.
  27. Luciani A, Polig E, Lloyd RD, Miller SC (2006 May). Americium in the beagle dog: biokinetic and dosimetric model. Health Phys, 90(5), 459-70.
  28. Lloyd RD, Taylor GN, Miller SC, Bruenger FW, Jee WS (2006 Jun). Ancestry of beagles in lifespan studies of radionuclide toxicity at the University of Utah. Health Phys, 90(6), 580-2.
  29. Liu G, Men P, Kenner GH, Miller SC (2006 Jun). Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation. Biometals, 19(3), 245-51.
  30. Miller SC, Bowman BM (2006). Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation. (Epub ahead of print) Anat Rec A Discov Mol Cell Evol Biol.
  31. Wang D, Sima M, Mosley RL, Davda JP, Tietze N, Miller SC, Gwilt PR, Kopeckova P, Kopecek J (2006 Nov-Dec). Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers. Mol Pharm, 3(6), 717-25.
  32. Warner SE, Shea JE, Miller SC, Shaw JM (2006 Dec). Adaptations in cortical and trabecular bone in response to mechanical loading with and without weight bearing. Calcif Tissue Int, 79(6), 395-403.
  33. Leggett RW, Eckerman KF, Khokhryakov VF, Suslova KG, Krahenbuhl MP, Miller SC (2005 Aug). Mayak worker study: an improved biokinetic model for reconstructing doses from internally deposited plutonium. Radiat Res, 164(2), 111-22.
  34. Gilbert ES, Koshurnikova NA, Sokolnikov ME, Shilnikova NS, Preston DL, Ron E, Khokhryokov VF, Vasilenko EK, Miller S, Eckerman K, Romanov SA (2005). Lung cancers in Mayak workers. Radiat Res, 162, 505-16.
  35. Khokhryakov VF, Suslova KG, Vostrotin VV, Romanov SA, Eckerman KF, Krahenbuhl MP, Miller SC (2005 Feb). Adaptation of the ICRP publication 66 respiratory tract model to data on plutonium biokinetics for Mayak workers. Health Phys, 88(2), 125-32.
  36. Miller SC, Anderson BL, Bowman BM (2005 Jul). Weaning initiates a rapid and powerful anabolic phase in the rat maternal skeleton. Biol Reprod, 73(1), 156-62.
  37. Lloyd RD, Thurman GB, Taylor GN, Miller SC (2005 May). Does the severity of radionuclide-induced skeletal malignancy depend upon radiation dose? Health Phys, 88(5), 491-6.
  38. Wang D, Miller SC, Kopecek J (2005 May 25). Targeted drug delivery for musculoskeletal diseases. Adv Drug Deliv Rev, 57(7), 935-7.
  39. Shea JE, Miller SC (2005 May 25). Skeletal function and structure: implications for tissue-targeted therapeutics. Adv Drug Deliv Rev, 57(7), 945-57.
  40. Wang D, Miller SC, Kopeckova P, Kopecek J (2005 May 25). Bone-targeting macromolecular therapeutics. Adv Drug Deliv Rev, 57(7), 1049-76.
  41. Kenner GH, Brik AB, Liu G, Haskell EH, Hayes RB, Knight JA, Vajda EG, Miller SC, Jee WS, Barrus JK (2005 Jun). Variation of long-lived free radicals responsible for the EPR native signal in bone of aged or diseased human females and ovariectomized adult rats. Radiat Meas, 39(3), 255-62.
  42. Krahenbuhl MP, Bess JD, Wilde JL, Vostrotin VV, Suslova KG, Khokhryakov VF, Slaughter DM, Miller SC (2005 Jul). Uncertainties analysis of doses resulting from chronic inhalation of plutonium at the Mayak production association. Health Phys, 89(1), 33-45.
  43. Miller SC, Wang D, Kopeckova P, Kopecek J (2005). Biopolymer-based delivery systems for advanced imaging and skeletal tissue-specific therapeutics. J Bone Miner Metab, 23 Suppl, 103-8.
  44. Lloyd RD, Bruenger FW, Taylor GN, Miller SC (2005 Jul-Aug). Search for a genetic link for mammary cancer in a beagle colony. In Vivo, 19(4), 723-7.
  45. Polig E, Lloyd RD, Bruenger FW, Miller SC (2004 Jan). Biokinetic model of radium in humans and beagles. Health Phys, 86(1), 42-55.
  46. Heap J, Murray MA, Miller SC, Jalili T, Moyer-Mileur LJ (2004 Jan). Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J Pediatr, 144(1), 56-62.
  47. Liu G, Men P, Kenner GH, Miller SC, Bruenger FW (2004). Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics. Nucleosides Nucleotides Nucleic Acids, 23(3), 599-611.
  48. Polig E, Bruenger FW, Lloyd RD, Miller SC (2004 Jun). Survival and bone tumor hazard from internal deposition of 226Ra in beagles. Health Phys, 86(6), 590-602.
  49. Lloyd RD, Taylor GN, Miller SC (2004 Jun). Does malignant hematopoietic disease result from internal exposure to 239Pu? Health Phys, 86(6), 625-8.
  50. Lloyd RD, Taylor GN, Miller SC (2004 Jun). Does low dose internal radiation increase lifespan? Health Phys, 86(6), 629-32.
  51. Wang D, Miller SC, Sima M, Parker D, Buswell H, Goodrich KC, Kopeckova P, Kopecek J (2004 Oct). The arthrotropism of macromolecules in adjuvant-induced arthritis rat model: a preliminary study. Pharm Res, 21(10), 1741-9.
  52. Wang D, Miller SC, Kopecek P, Kopecek J (2003). Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery system. Bioconjug Chem, 14, 853-9.
  53. Lloyd RD, Taylor GN, Miller SC (2003 Jan). Does soft tissue cancer affect the development of radionuclide-induced skeletal malignancy? Health Phys, 84(1), 111-4.
  54. Blum SC, Heaton SN, Bowman BM, Hegsted M, Miller SC (2003 May). Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. J Nutr, 133(5), 1244-9.
  55. Shea JE, Miller SC, Poole DC, Mattson JP (2003 Aug). Cortical bone dynamics, strength, and densitometry after induction of emphysema in hamsters. J Appl Physiol, 95(2), 631-4.
  56. Runyan SM, Stadler DD, Bainbridge CN, Miller SC, Moyer-Mileur LJ (2003 Oct). Familial resemblance of bone mineralization, calcium intake, and physical activity in early-adolescent daughters, their mothers, and maternal grandmothers. J Am Diet Assoc, 103(10), 1320-5.
  57. Suslova KG, Khokhryakov VF, Tokarskaya ZB, Nifatov AP, Sokolova AB, Kudryavtzeva TI, Miller SC, Krahenbuhl MP (2003). The effect of state of health on organ distribution and excretion of systemic plutonium in the Mayak workers. Radiat Prot Dosimetry, 105(1-4), 229-33.
  58. Miller SC, Lloyd RD, Bruenger FW, Krahenbuhl MP, Polig E, Romanov SA (2003 Nov). Comparisons of the skeletal locations of putative plutonium-induced osteosarcomas in humans with those in beagle dogs and with naturally occurring tumors in both species. Radiat Res, 160(5), 517-23.
  59. Shea JE, Bowman BM, Miller SC (2003 Sep). Alterations in skeletal and mineral metabolism following thermal injuries. J Musculoskelet Neuronal Interact, 3(3), 214-22.
  60. Khokhryakov VF, Suslova KG, Vostrotin VV, Romanov SA, Menshikh ZS, Kudryavtseva TI, Filipy RE, Miller SC, Krahenbuhl MP (2002 Apr). The development of the plutonium lung clearance model for exposure estimation of the Mayak production association, nuclear plant workers. Health Phys, 82(4), 425-31.
  61. Suslova KG, Khokhryakov VF, Tokarskaya ZB, Nifatov AP, Krahenbuhl MP, Miller SC (2002 Apr). Extrapulmonary organ distribution of plutonium in healthy workers exposed by chronic inhalation at the Mayak production association. Health Phys, 82(4), 432-44.
  62. Krahenbuhl MP, Slaughter DM, Wilde JL, Bess JD, Miller SC, Khokhryakov VF, Suslova KG, Vostrotin VV, Romanov SA, Menshikh ZS, Kudryavtseva TI (2002 Apr). The historical and current application of the FIB-1 model to assess organ dose from plutonium intakes in Mayak workers. Health Phys, 82(4), 445-54.
  63. Barry AB, Baig AA, Miller SC, Higuchi WI (2002 Aug). Effect of age on rat bone solubility and crystallinity. Calcif Tissue Int, 71(2), 167-71.
  64. Miller SC, Bowman BM, Siska CC, Shelby J (2002 Nov). Effects of thermal injury on skeletal metabolism in two strains of mice. Calcif Tissue Int, 71(5), 429-36.
  65. Bowman BM, Siska CC, Miller SC (2002 Nov). Greatly increased cancellous bone formation with rapid improvements in bone structure in the rat maternal skeleton after lactation. J Bone Miner Res, 17(11), 1954-60.
  66. Miller SC (2002 Dec). Radionuclide-induced skeletal cancers. J Musculoskelet Neuronal Interact, 2(6), 552-3.
  67. Hart KJ, Shaw JM, Vajda E, Hegsted M, Miller SC (2001-10-01). Swim-trained rats have greater bone mass, density, strength, and dynamics. J Appl Physiol, 91(87507587).
  68. Polig E, Bruenger FW, Lloyd RD, Miller SC (2001). Model for the occurrence of bone tumors in beagles. Math Comput Model, 33, 1315-22.
  69. Tsodikov A, Bruenger FS, Lloyd RD, Miller SC, Polig E, Yakovlev AJ (2001). Modeling and analysis of the latent period of osteosarcomas induced by incorporated radionuclides: the role of the immune responses. Math Comput Model, 33, 1377-86.
  70. Vajda EG, Wronski TJ, Halloran BP, Bachus KN, Miller SC (2001 Aug). Spaceflight alters bone mechanics and modeling drifts in growing rats. Aviat Space Environ Med, 72(8), 720-6.
  71. Vajda EG, Bowman BM, Miller SC (2001 Sep). Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat. Biol Reprod, 65(3), 689-95.
  72. Hart KJ, Shaw JM, Vajda E, Hegsted M, Miller SC (2001 Oct). Swim-trained rats have greater bone mass, density, strength, and dynamics. J Appl Physiol, 91(4), 1663-8.
  73. Lloyd RD, Miller SC, Taylor GN (2001 Oct). Does longevity in beagles injected with bone-seeking radionuclides depend upon radiation dose in the absence of known radiation effects? Health Phys, 81(4), 456-9.
  74. Bowman BM, Miller SC (2001 Jun). Skeletal adaptations during mammalian reproduction. J Musculoskelet Neuronal Interact, 1(4), 347-55.
  75. Vasilenko EK, Smetanin MY, Knyazev VA, Miller SC, Slaughter M, Jacob P, Feherbaher G (2000). Approach to retrospective reconstruction of the photon exposure spectra distribution at technological sites of the Mayak Production Association (Russian Federal Ministry of Atomic Energy) (article in Russian). Radiation Safety Problems, 3, 42-50.
  76. Polig E, Bruenger FW, Lloyd RD, Miller SC (2000 Feb). Biokinetic and dosimetric model of plutonium in the dog. Health Phys, 78(2), 182-90.
  77. Picherit C, Coxam V, Oudadesse H, Martini B, Gaumet N, Davicco MJ, Lebecque P, Miller S, Irrigaray JL, Barlet JP (2000 Mar). Dihydrotestosterone prevents glucocorticoid-negative effects on fetal rat metatarsal bone in vitro. Biol Neonate, 77(3), 181-90.
  78. Chin J, Miller SC, Wada M, Nagano N, Nemeth EF, Fox J (2000 May). Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. J Am Soc Nephrol, 11(5), 903-11.
  79. Lloyd RD, Taylor GN, Miller SC (2000 Jun). Fracture occurrence from radionuclides in the skeleton. Health Phys, 78(6), 687-92.
  80. Khokhryakov V, Suslova K, Aladova E, Vasilenko E, Miller SC, Slaughter DM, Krahenbuhl MP (2000 Jul). Development of an improved dosimetry system for the workers at the Mayak Production Association. Health Phys, 79(1), 72-6.
  81. Hunziker J, Wronski TJ, Miller SC (2000 Jun). Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone. J Dent Res, 79(6), 1431-8.
  82. Taylor GN, Lloyd RD, Miller SC, Muggenburg BA (2000 Aug). Radium-induced eye melanomas in dogs. Health Phys, 79(2), 196-8.
  83. Lloyd RD, Taylor GN, Miller SC (2000 Aug). Does body size contribute to sensitivity of bone tumor induction by radionuclide exposure? Health Phys, 79(2), 199-202.
  84. Koshurnikova NA, Gilbert ES, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, Romanov SA, Shilnikova NS, Suslova KG, Vostrotin VV (2000 Sep). Bone cancers in Mayak workers. Radiat Res, 154(3), 237-45.
  85. Gilbert ES, Koshurnikova NA, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, Romanov SA, Shilnikova NS, Suslova KG, Vostrotin VV (2000 Sep). Liver cancers in Mayak workers. Radiat Res, 154(3), 246-52.
  86. Howe EE, Wronski TJ, Halloran BP, Miller SC (2000 Oct). Histologic changes in the adrenal cortex from young rats following spaceflight. Aviat Space Environ Med, 71(10), 1039-44.
  87. Lloyd RD, Taylor GN, Fisher DR, Schlenker RA, Miller SC (2000 Dec). Effective thresholds for induction of skeletal malignancies by radionuclides. Health Phys, 79(6), 722-7.
  88. Liu G, Arif AM, Bruenger FW, Miller SC (1999). A new linear polymeric chain iron complex; synthesis, crystal and molecular characterization of catena-ยต-acetato-[N,N'-ethylenebis(salicyaldiminato)]iron(III). Inorg Chim Acta, 287, 109-12.
  89. Lloyd RD, Miller SC, Taylor GN, Bowman BM (1999). . Is there a difference in radionuclide-induced bone tumor sensitivity between male and female beagles? Health Phys, 77, 178-82.
  90. Lloyd RD, Miller SC, Taylor GN, Bowman BM (1999 Aug). Is there a difference in radionuclide-induced bone tumor sensitivity between male and female beagles? Health Phys, 77(2), 178-82.
  91. Lloyd RD, Taylor GN, Jee WS, Miller SC (1999 Jan). Relative radiosensitivity of bone tumor induction among beagles as a function of age at injection of 239Pu or 226Ra. Health Phys, 76(1), 50-6.
  92. Lloyd RD, Fisher DR, Schlenker RA, Miller SC (1999 Apr). Some problems in the skeletal dosimetry of bone-seeking radionuclides. Health Phys, 76(4), 402-12.
  93. Baig AA, Fox JL, Wang Z, Higuchi WI, Miller SC, Barry AM, Otsuka M (1999 Apr). Metastable equilibrium solubility behavior of bone mineral. Calcif Tissue Int, 64(4), 329-39.
  94. Chang W, Tu C, Bajra R, Komuves L, Miller S, Strewler G, Shoback D (1999 Apr). Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells. Endocrinology, 140(4), 1911-9.
  95. Vajda EG, Kneissel M, Muggenburg B, Miller SC (1999 Dec). Increased intracortical bone remodeling during lactation in beagle dogs. Biol Reprod, 61(6), 1439-44.
  96. Bowman BM, Miller SC (1999 Nov). Skeletal mass, chemistry, and growth during and after multiple reproductive cycles in the rat. Bone, 25(5), 553-9.
  97. Chang W, Tu C, Chen TH, Komuves L, Oda Y, Pratt SA, Miller S, Shoback D (1999 Dec). Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology, 140(12), 5883-93.
  98. Wilson AK, Bhattacharyya MH, Miller S, Mani A, Sacco-Gibson N (1998 Mar). Ovariectomy-induced changes in aged beagles: histomorphometry of rib cortical bone. Calcif Tissue Int, 62(3), 237-43.
  99. Miller SC, Bowman BM (1998 Jun). Comparison of bone loss during normal lactation with estrogen deficiency osteopenia and immobilization osteopenia in the rat. Anat Rec, 251(2), 265-74.
  100. Wronski TJ, Li M, Shen Y, Miller SC, Bowman BM, Kostenuik P, Halloran BP (1998 Jul). Lack of effect of spaceflight on bone mass and bone formation in group-housed rats. J Appl Physiol, 85(1), 279-85.
  101. Polig E, Bruenger FW, Lloyd RD, Miller SC (1998 Sep). Microdistribution of 239Pu in the beagle skeleton. Health Phys, 75(3), 251-8.
  102. Miller MA, Chin J, Miller SC, Fox J (1998 Sep). Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency. Bone, 23(3), 257-66.
  103. Lloyd RD, Thurman GB, Taylor GN, Miller SC (1998 Oct). Does age of the host affect growth rates of skeletal malignancies? Health Phys, 75(4), 422-3.
  104. Liu G, Bruenger FW, Miller SC, Arif AM (1998 Nov 3). Molecular structure and biological and pharmacological properties of 3-hydroxy-2-methyl-1-(beta-D-ribofuranosyl or pyranosyl)-4-pyridinone: potential iron overload drugs for oral administration. Bioorg Med Chem Lett, 8(21), 3077-80.
  105. Shi Y, Eyring EM, Eldik R, Liu G, Bruenger FW, Miller SC (1997). Kinetics and mechanisms of Fe(III) complexation by lipophilic 3-hydroxy-2-methyl-1(gamma-steroamidopropyl)-4-pyridinone (HMSP). J Biol Inorg Chem, 2, 728-48.
  106. Edelman LS, Shao W, Miller SC, Bowman B, Morris SE, Shelby J (1997). Effects of burn injury on bone and growth in a mouse model. (The 1997 Lindberg Award). J Burn Care Res, 18, 483-9.
  107. Miller SC (1997). Models of skeletal osteopenia in the rat. J Histotech, 20, 209-13.
  108. Bowman BM, Miller SC (1997 Apr). Endochondral bone growth during early pregnancy compared with pseudopregnancy in rats. Endocrine, 6(2), 173-7.
  109. Miller SC, Hunziker J, Mecham M, Wronski TJ (1997 Aug). Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res, 76(8), 1471-6.
  110. Fox J, Miller MA, Stroup GB, Nemeth EF, Miller SC (1997 Aug). Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion. Bone, 21(2), 163-9.
  111. Bagi CM, Ammann P, Rizzoli R, Miller SC (1997 Oct). Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif Tissue Int, 61(4), 336-44.
  112. Taylor GN, Lloyd RD, Mays CW, Miller SC, Jee WS, Mori S, Shabestari L, Li XJ (1997 Oct). Relationship of natural incidence and radiosensitivity for bone cancer in dogs. Health Phys, 73(4), 679-83.
  113. Lloyd RD, Taylor GN, Miller SC, Bruenger FW, Jee WS (1997 Oct). Bone tumor location in dogs given skeletal irradiation by 239Pu or 226Ra. Health Phys, 73(4), 684-9.
  114. Chamoux E, Coxam V, Lebecque P, Davicco MJ, Miller SC, Barlet JP (1997 Summer). Influence of sex steroids on development of cultured fetal rat metatarsal bones. Growth Dev Aging, 61(2), 79-91.
  115. Bowman BM, Miller SC (1996 Jan). Elevated progesterone during pseudopregnancy may prevent bone loss associated with low estrogen. J Bone Miner Res, 11(1), 15-21.
  116. Coxam V, Miller MA, Bowman MB, Miller SC (1996). Ontogenesis of IGF regulation of longitudinal bone growth in rat metatarsal rudiments cultured in serum-free medium. Arch Physiol Biochem, 104(2), 173-9.
  117. LLoyd RD, Polig E, Taylor GN, Bruenger FW, Miller SC (1996 Mar). Uranium skeletal dosimetry and distribution in young adult beagles: a guide for calculating uranium skeletal doses in humans. Health Phys, 70(3), 396-401.
  118. Bagi CM, DeLeon E, Ammann P, Rizzoli R, Miller SC (1996 Aug). Histo-anatomy of the proximal femur in rats: impact of ovariectomy on bone mass, structure, and stiffness. Anat Rec, 245(4), 633-44.
  119. Coxam V, Bowman BM, Mecham M, Roth CM, Miller MA, Miller SC (1996 Aug). Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats. Bone, 19(2), 107-14.
  120. Liu G, Bruenger FW, Barrios AL, Miller SC (1995). Synthesis of 2-alkyl-3-hydroxy-4-pyridinone-ribonucleosides,- Potential oral iron chelators. Nucleosides Nucleotides, 14, 1901-4.
  121. Liu G, Miller SC, Bruenger FW (1995). Synthesis of lipophilic 3-hydroxy-2-methyl-4-pyridinone derivatives. Synth Commun, 25, 3247-53.
  122. Coxam V, Miller MA, Bowman BM, Qi D, Miller SC (1995). Insulin-like growth factor 1 and parathyroid hormone effects on the growth of fetal rat metatarsal bones cultured in serum-free medium. Biol Neonate, 68(5), 368-76.
  123. Lloyd RD, Taylor GN, Angus W, Miller SC (1995 Feb). Soft tissue tumors in beagles injected with 241Am citrate. Health Phys, 68(2), 225-33.
  124. Taylor GN, Lloyd RD, Mays CW, Angus W, Miller S, Hubbs A (1995 Aug). Fission fragment relative biological effectiveness for liver tumor induction. Health Phys, 69(2), 269-71.
  125. Lloyd RD, Angus W, Taylor GN, Miller SC (1995 Aug). Soft tissue tumors among beagles injected with 90Sr, 228Ra, OR 228Th. Health Phys, 69(2), 272-7.
  126. Lloyd RD, Bruenger FW, Angus W, Taylor GN, Miller SC (1995 Sep). Mammary tumor occurrence in beagles given 239Pu. Health Phys, 69(3), 385-90.
  127. Lloyd RD, Angus W, Taylor GN, Bruenger FW, Miller SC (1995 Oct). Soft tissue tumors induced by monomeric 239Pu. Health Phys, 69(4), 530-7.
  128. Smutz WP, Miller SC, Eaton C, Bloswick DS, France EP (1994). Investigation of low force, high frequency activities on development of carpal tunnel syndrome. Clin Biomech (Bristol, Avon), 9, 15-20.
  129. Lloyd RD, Taylor GN, Angus W, Miller SC, Boecker BB (1994 Feb). Skeletal malignancies among beagles injected with 241Am. Health Phys, 66(2), 172-7.
  130. Lloyd RD, Taylor GN, Angus W, Bruenger FW, Miller SC (1994 Mar). Soft-tissue tumors among beagles injected with 226Ra. Health Phys, 66(3), 283-92.
  131. Lloyd RD, Angus W, Taylor GN, Thurman GB, Miller SC (1994 Mar). Occurrence of metastases in beagles with skeletal malignancies induced by internal irradiation. Health Phys, 66(3), 293-9.
  132. Lloyd RD, Taylor GN, Angus W, Bruenger FW, Miller SC (1994 Mar). Eye tumors and other lesions among beagles given 90Sr or 226Ra. Health Phys, 66(3), 346-9.
  133. Marks SC Jr, Miller SC (1994 Mar). Local delivery of prostaglandin E1 induces periodontal regeneration in adult dogs. J Periodontal Res, 29(2), 103-8.
  134. Lloyd RD, Taylor GN, Angus W, Miller SC, Bruenger FW, Jee WS (1994 Apr). Distribution of skeletal malignancies in beagles injected with 239Pu citrate. Health Phys, 66(4), 407-13.
  135. Rosen D, Miller SC, DeLeon E, Thompson AY, Bentz H, Mathews M, Adams S (1994 May-Jun). Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone, 15(3), 355-9.
  136. Bruenger FW, Lloyd RD, Miller SC, Taylor GN, Angus W, Huth DA (1994 Jun). Occurrence of mammary tumors in beagles given radium-226. Radiat Res, 138(3), 423-34.
  137. Bagi CM, Miller SC (1994 Jul). Comparison of osteopenic changes in cancellous bone induced by ovariectomy and/or immobilization in adult rats. Anat Rec, 239(3), 243-54.
  138. Lloyd RD, Miller SC, Taylor GN, Bruenger FW, Jee WS, Angus W (1994 Oct). Relative effectiveness of 239Pu and some other internal emitters for bone cancer induction in beagles. Health Phys, 67(4), 346-53.
  139. Lloyd RD, Taylor GN, Angus W, Bruenger FW, Miller SC (1993 Jan). Bone cancer occurrence among beagles given 239Pu as young adults. Health Phys, 64(1), 45-51.
  140. Miller SC, Marks SC Jr (1993 Mar-Apr). Local stimulation of new bone formation by prostaglandin E1: quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets. Bone, 14(2), 143-51.
  141. Miller SC, Marks SC Jr (1993 May-Jun). Alveolar bone augmentation following the local administration of prostaglandin E1 by controlled-release pellets. Bone, 14(3), 587-93.
  142. Taylor GN, Lloyd RD, Bruenger FW, Miller SC (1993 Jun). 241Am-induced thyroid lesions in the beagle. Health Phys, 64(6), 653-60.
  143. Miller SC, Wronski TJ (1993 Jul). Long-term osteopenic changes in cancellous bone structure in ovariectomized rats. Anat Rec, 236(3), 433-41.
  144. Miller SC, Bruenger FW, Kuswik-Rabiega G, Liu G, Lloyd RD (1993 Oct). Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium. J Pharmacol Exp Ther, 267(1), 548-54.
  145. Bagi CM, Mecham M, Weiss J, Miller SC (1993 Nov-Dec). Comparative morphometric changes in rat cortical bone following ovariectomy and/or immobilization. Bone, 14(6), 877-83.
  146. Simmons DJ, Menton DN, Miller S, Lozano R (1993 Dec). Periosteal attachment fibers in the rat calvarium. Calcif Tissue Int, 53(6), 424-7.
  147. Kuswik-Rabiega G, Bruenger FW, Miller SC (1992). Regiospecific synthesis of mono- or diacetylated polyethylenepolyamine derivatives. Synth Commun, 22, 1307-18.
  148. Bagi CM, Miller SC (1992 Jan). Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium. J Bone Miner Res, 7(1), 29-40.
  149. Bagi CM, Miller SC, Bowman BM, Blomstrom GL, France EP (1992). Differences in cortical bone in overloaded and underloaded femurs from ovariectomized rats: comparison of bone morphometry with torsional testing. Bone, 13(1), 35-40.
  150. Bruenger FW, Kuswik-Rabiega G, Miller SC (1992 Jan). Decorporation of aged americium deposits by oral administration of lipophilic polyamino carboxylic acids. J Med Chem, 35(1), 112-8.
  151. Taylor GN, Lloyd RD, Mays CW, Shabestari L, Miller SC (1992 Feb). Promotion of radiation-induced liver neoplasia by ethanol. Health Phys, 62(2), 178-82.
  152. de Saint-Georges L, Miller SC (1992 Jun). The microcirculation of bone and marrow in the diaphysis of the rat hemopoietic long bones. Anat Rec, 233(2), 169-77.
  153. Miller SC, Bruenger FW, Kuswik-Rabiega G, Lloyd RD (1992 Aug). Decorporation of plutonium by oral administration of a partially lipophilic polyaminocarboxylic acid. Health Phys, 63(2), 195-7.
  154. Miller SC, Bowman BM, Miller MA, Bagi CM (1991). Calcium absorption and osseous organ-, tissue-, and envelope-specific changes following ovariectomy in rats. Bone, 12(6), 439-46.
  155. Lloyd RD, Bruenger FW, Miller SC, Angus W, Taylor GN, Jee WS, Polig E (1991 Mar). Distribution of radium-induced bone cancers in beagles and comparison with humans. Health Phys, 60(3), 435-8.
  156. Bruenger FW, Lloyd RD, Miller SC (1991 Mar). The influence of age at time of exposure to 226Ra or 239Pu on distribution, retention, postinjection survival, and tumor induction in beagle dogs. Radiat Res, 125(3), 248-56.
  157. Bruenger FW, Miller SC, Lloyd RD (1991 Jun). A comparison of the natural survival of beagle dogs injected intravenously with low levels of 239Pu, 226Ra, 228Ra, 228Th, or 90Sr. Radiat Res, 126(3), 328-37.
  158. Bagi CM, Miller SC (1991 Aug). Ultrastructure, tartrate-resistant acid phosphatase activity and calcitonin responsiveness of osteoclasts at sites of demineralized bone matrix implant-induced osteogenesis. Clin Orthop Relat Res, (269), 257-65.
  159. Taylor GN, Lloyd RD, Mays CW, Angus W, Miller SC, Shabestari L, Hahn FF (1991 Sep). Plutonium- or americium-induced liver tumors and lesions in beagles. Health Phys, 61(3), 337-47.
  160. Bruenger FW, Lloyd RD, Taylor GN, Miller SC, Mays CW (1990 Jun). Kidney disease in beagles injected with polonium-210. Radiat Res, 122(3), 241-51.
  161. Miller MA, Omura TH, Miller SC (1989). Increased cancellous bone remodeling during lactation in beagles. Bone, 10(4), 279-85.
  162. Miller SC, Bruenger FW, Williams FW (1989 Apr). Influence of age at exposure on concentrations of 239Pu in beagle gonads. Health Phys, 56(4), 485-91.
  163. Quan-Sheng D, Miller SC (1989 Jul). Calciotrophic hormone levels and calcium absorption during pregnancy in rats. Am J Physiol, 257(1 Pt 1), E118-23.
  164. Bagi CM, Miller SC (1989 Sep). Osteoclast features of cells that resorb demineralized and mineral-containing bone implants in rats. Scanning Microsc, 3(3), 963-8; discussion 969-70.
  165. de Saint-Georges L, Miller SC, Bowman BM, Jee WS (1989 Dec). Ultrastructural features of osteoclasts in situ. Scanning Microsc, 3(4), 1201-5; discussion 1205-6.
  166. Brommage R, Miller SC, Langman CB, Bouillon R, Smith R, Bourdeau JE (1988). The effects of chronic vitamin D deficiency on the skeleton in the adult rabbit. Bone, 9(3), 131-9.
  167. Miller SC, Miller MA, Omura TH (1988 Jan). Dietary lactose improves endochondral growth and bone development and mineralization in rats fed a vitamin D-deficient diet. J Nutr, 118(1), 72-7.
  168. Jee WS, Miller SC, Li XJ, DeSalva S (1988 Mar 15). Effects of N,N,N',N'-ethylenediaminetetramethylene phosphonic acid on cortical bone remodeling in the adult dog. Toxicol Appl Pharmacol, 92(3), 335-42.
  169. Marks SC Jr, Miller S (1988 Nov). Local infusion of prostaglandin E1 stimulates mandibular bone formation in vivo. J Oral Pathol, 17(9-10), 500-5.
  170. Paschoa AS, Wrenn ME, Singh NP, Bruenger FW, Miller SC, Cholewa M, Jones KW (1987 Aug). Localization of vanadium-containing particles in the lungs of uranium/vanadium miners. Biol Trace Elem Res, 13(1), 275-282.
  171. Paschoa AS, Wrenn ME, Singh NP, Bruenger FW, Miller SC, Cholewa A, Jones KW (1987). Localization of vanadium-containing particles in the lungs of uranium/vanadium miners. Biol Trace Elem Res, 13, 275-82.
  172. Cholewa M, Jones KW, Paschoa AS, Miller SC, Pecotte J (1987). Elemental concentrations in bones from an ancient Egyptian mummy and from a contemporary man. Nucl Instrum Meth Phys Res, B22, 423-5.
  173. Lloyd RD, Wrenn ME, Taylor GN, Mays CW, Jee WSS, Bruenger FW, Miller SC, Paschoa AS (1986). Toxicity of Ra-228 and Th-228 relative to Ra-226 for bone sarcoma induction. Strahlentherapie [Sonderb], 80(Suppl), 65-9.
  174. Jee WSS, Parks NJ, Miller SC, Dell RB (1986). . Relationship of bone composition to the location of radium-induced bone cancer. Strahlentherapie [Sonderb], 80(Suppl), 75-8.
  175. Miller SC, Shupe JG, Redd EH, Miller MA, Omura TH (1986). Changes in bone mineral and bone formation rates during pregnancy and lactation in rats. Bone, 7(4), 283-7.
  176. Bowman BM, Miller SC (1986). The proliferation and differentiation of the bone-lining cell in estrogen-induced osteogenesis. Bone, 7(5), 351-7.
  177. Strewler GJ, Wronski TJ, Halloran BP, Miller SC, Leung SC, Williams RD, Nissenson RA (1986 Jul). Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma. Endocrinology, 119(1), 303-10.
  178. Miller SC, Rowland HG, Bowman BM (1985 Jan). Distributions of cell populations within alpha-particle range of plutonium deposits in the rat and beagle testis. Radiat Res, 101(1), 102-10.
  179. Miller SC, Jee WS, Woodbury DM, Kemp JW (1985 Feb). Effects of N,N,N',N'-ethylenediaminetetramethylene phosphonic acid and 1-hydroxyethylidene-1,1-bisphosphonic acid on calcium absorption, plasma calcium, longitudinal bone growth, and bone histology in the growing rat. Toxicol Appl Pharmacol, 77(2), 230-9.
  180. Miller SC, Kenny AD (1985 May). Activation of avian medullary bone osteoclasts by oxidized synthetic parathyroid hormone (1-34). Proc Soc Exp Biol Med, 179(1), 38-43.
  181. Miller SC, Omura TH, Smith LJ (1985 Aug). Changes in dentin appositional rates during pregnancy and lactation in rats. J Dent Res, 64(8), 1062-4.
  182. Miller SC (1985 Sep). The rapid appearance of acid phosphatase activity at the developing ruffled border of parathyroid hormone activated medullary bone osteoclasts. Calcif Tissue Int, 37(5), 526-9.
  183. Bruenger FW, Smith JM, Atherton DR, Miller SC, Jee WS, Stevens W (1984 Feb). Radiation dose rates to the proximal humerus of growing beagles injected with 239Pu. Radiat Res, 97(2), 302-17.
  184. Miller SC, Bowman BM, Myers RL (1984 Feb). Morphological and ultrastructural aspects of the activation of avian medullary bone osteoclasts by parathyroid hormone. Anat Rec, 208(2), 223-31.
  185. Smith JM, Miller SC, Jee WS (1984 Aug). The relationship of bone marrow type and microvasculature to the microdistribution and local dosimetry of plutonium in the adult skeleton. Radiat Res, 99(2), 324-35.
  186. Redd EH, Miller SC, Jee WS (1984 Dec). Changes in endochondral bone elongation rates during pregnancy and lactation in rats. Calcif Tissue Int, 36(6), 697-701.
  187. Miller SC, Bowman BM, Roberts LK (1984 Dec). Identification and characterization of mononuclear phagocytes isolated from rat testicular interstitial tissues. J Leukoc Biol, 36(6), 679-87.
  188. Paschoa AS, Wrenn ME, Miller SC, Jones KW, Cholewa M, Hanson AL (1983 Fall). MicroPIXE as a tool to search for uranium-bearing particles in lung tissues. Neurotoxicology, 4(3), 205-10.
  189. Miller SC, Bowman BM (1983 May). Tissue, cellular, and subcellular distribution of 241Pu in the rat testis. Radiat Res, 94(2), 416-26.
  190. Miller SC, Halloran BP, DeLuca HF, Jee WS (1983 Jul). Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif Tissue Int, 35(4-5), 455-60.
  191. Das HR, Codington JF, Lampert LA, Maxfield MD, Jeanloz RW, Miller SC, Klein G, Dalianis T (1983 Aug 16). Studies on the possible chemical, immunochemical and morphological differences at the cell surfaces of immunosensitive and immunoresistant, Moloney virus-induced, lymphoma cell-lines. Carbohydr Res, 120, 303-14.
  192. Miller SC, Bowman BM, Rowland HG (1983 Sep). Structure, cytochemistry, endocytic activity, and immunoglobulin (Fc) receptors of rat testicular interstitial-tissue macrophages. Am J Anat, 168(1), 1-13.
  193. Codington JF, Dalianis T, Miller SC, Das HR, Klein G, Lampert LA, Silber C, Darby DM, Jeanloz RW (1983 Sep). Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A. Cancer Res, 43(9), 4364-72.
  194. Codington JF, Das HR, Dalianis T, Klein G, Miller SC, Silber C, Lampert LA, Darby DM, Jeanloz RW (1983 Sep). Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection. Cancer Res, 43(9), 4373-81.
  195. Miller SC, Halloran BP, DeLuca HF, Jee WS (1982 May). Role of vitamin D in maternal skeletal changes during pregnancy and lactation: a histomorphometric study. Calcif Tissue Int, 34(3), 245-52.
  196. Miller SC, Codington JF, Klein G (1982 Jun). Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell. J Natl Cancer Inst, 68(6), 981-8.
  197. Miller SC (1982 Jun). Localization of plutonium-241 in the testis. An interspecies comparison using light and electron microscope autoradiography. Int J Radiat Biol Rlat Stud Phys Chem Med, 41(6), 633-43.
  198. Miller SC, Marks SC Jr (1982 Jul). Osteoclast kinetics in osteopetrotic (ia) rats cured by spleen cell transfers from normal littermates. Calcif Tissue Int, 34(4), 422-7.
  199. Miller SC, Halloran BP, DeLuca HF, Yamada S, Takayama H, Jee WS (1981). Studies on the role of 24-hydroxylation of vitamin D in the mineralization of cartilage and bone of vitamin D-deficient rats. Calcif Tissue Int, 33(5), 489-97.
  200. Miller SC (1981 Sep). Osteoclast cell-surface specializations and nuclear kinetics during egg-laying in Japanese quail. Am J Anat, 162(1), 35-43.
  201. Miller SC, Bowman BM (1981 Oct 15). Medullary bone osteogenesis following estrogen administration to mature male Japanese quail. Dev Biol, 87(1), 52-63.
  202. Miller SC, Jee WSS (1980). The microvascular bed of fatty bone marrow in the adult beagle. Metab Bone Dis Relat Res, 2, 239-46.
  203. Miller SC, Bowman BM, Smith JM, Jee WS (1980 Oct). Characterization of endosteal bone-lining cells from fatty marrow bone sites in adult beagles. Anat Rec, 198(2), 163-73.
  204. Miller SC, Jee WS (1979 Mar). The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat Rec, 193(3), 439-62.
  205. Miller SC (1978 Mar). Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone. J Cell Biol, 76(3), 615-8.
  206. Miller SC, Jee WS, Kimmel DB, Woodbury L (1977 Feb 11). Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei. Calcif Tissue Res, 22(3), 243-52.
  207. Miller SC, Hay ED, Codington JF (1977 Mar). Ultrastructural and histochemical differences in cell surface properties of strain-specific and nonstrain-specific TA3 adenocarcinoma cells. J Cell Biol, 72(3), 511-29.
  208. Miller SC (1977 Oct). Osteoclast cell-surface changes during the egg-laying cycle in Japanese quail. J Cell Biol, 75(1), 104-18.
  209. Miller SC, Jee WS (1977 Oct 20). The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia. Calcif Tissue Res, 23(3), 207-14.
  210. Miller SC, Jee WS (1975 Sep 5). Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia. Calcif Tissue Res, 18(3), 215-31.

Review

  1. Suslova KG, Khokhryakov VF, Sokolova AB, Miller SC (2012 Mar). 238Pu: a review of the biokinetics, dosimetry, and implications for human exposures. [Review]. Health Phys, 102(3), 251-62.
  2. Liu XM, Miller SC, Wang D (2010 Feb 17). Beyond oncology--application of HPMA copolymers in non-cancerous diseases. [Review]. Adv Drug Deliv Rev, 62(2), 258-71.
  3. Vrotsos Y, Miller SC, Marks SC Jr (2003). Prostaglandin E--a powerful anabolic agent for generalized or site-specific bone formation. [Review]. Crit Rev Eukaryot Gene Expr, 13(2-4), 255-63.
  4. Lloyd RD, Taylor GN, Miller SC, Bruenger FW, Jee WS (2001 Dec). Review of 239Pu and 226Ra effects in beagles. [Review]. Health Phys, 81(6), 691-7.
  5. Miller SC, Liu G, Bruenger FW (1997). Orally administered chelation agents effective for the removal of americium and plutonium. A review. [Review]. Ukrainian Journal of Radiology, 5, 439-40.
  6. Lloyd RD, Miller SC, Taylor GN, Bruenger FW, Angus W, Jee WS (1997 Jan). Comparison of internal emitter radiobiology in animals and humans. [Review]. Health Phys, 72(1), 100-10.
  7. Miller SC, Bowman BM, Jee WS (1995 Oct). Available animal models of osteopenia--small and large. [Review]. Bone, 17(4 Suppl), 117S-123S.
  8. Miller SC, Marks SC Jr (1994 Jul). Effects of prostaglandins on the skeleton. [Review]. Clin Plast Surg, 21(3), 393-400.
  9. Marks SC Jr, Miller SC (1993). Prostaglandins and the skeleton: the legacy and challenges of two decades of research. [Review]. Endocrine, 1, 337-44.
  10. Iizuka T, Miller SC, Marks SC Jr (1992 Apr). Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats. [Review]. J Oral Pathol Med, 21(4), 150-5.
  11. Miller SC, de Saint-Georges L, Bowman BM, Jee WS (1989 Sep). Bone lining cells: structure and function. [Review]. Scanning Microsc, 3(3), 953-60; discussion 960-1.

Book

  1. Khosrow B Semnani (). Preface to "The Ayatollah's Nuclear Gamble". Hinckley Institute of Politics at the Universitry of Utah and Omid for Iran.

Book Chapter

  1. Boecker BB, Griffith WS, Guilmette RA, Hahn FF, Muggenburg BA, Miller SC, Lloyd RD, Taylor GN (1995). The role of laboratory animals in studying the late-occurring effects of radionuclides deposited in the liver and skeleton. In van Kaick G, Karaoglou A, Kellerer AM (Eds.), Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (pp. 287-98). New Jersey: World Scientific Publishing Company.
  2. Ferguson DK, Miller SC, Marks SC Jr (1994). Augmentation of alveolar bone and associated soft tissues following the administration of prostaglandin E1 in dogs. In Davidovitch Z (Ed.), Biological Mechanisms of Tooth Eruption, Resorption and Replacement by Implants (pp. 199-208). Boston, MA: Harvard Society for the Advancement of Orthodontics.
  3. Miller SC (1992). Calcium homeostasis and mineral turnover in the laying hen. In Whitehead CC (Ed.), Bone Biology and Skeletal Disorders in Poultry (pp. 103-16). Oxford: Butterworth and Heinemann.
  4. Marks SC Jr, Larson EK, Bowman BM, Miller SC (1992). Local induction of alveolar bone in adult dogs by infusion of prostaglandin E1. In Davidovitch Z (Ed.), Biological Mechanisms of Tooth Eruption and Craniofacial Adaptation (pp. 137-43). Ohio State University Press.
  5. Marks SC Jr, Osier LK, Miller SC (1992). The role of prostaglandins in bone formation. In Habal MB, Reddi AH (Eds.), Bone Grafts: From Basic Science to Clinical Application (pp. 226-34). Philadelphia, PA: W. B. Saunders Company.
  6. Miller SC, Jee WSS (1992). Bone lining cells. In Hall BK (Ed.), Bone: Vol 4: Bone Metabolism and Mineralization (pp. 1-19). Boca Raton, FL: CRC Press.
  7. Marks SC Jr, Miller SC (1991). Site-directed formation of new lamellar bone in adult dogs by infusion of prostaglandin E1. In Dixon AD, Sarnat BG, Hoyte DAN (Eds.), Fundamentals of Bone Growth: Methodology and Applications (pp. 375-81). Boca Raton, FL: CRC Press.
  8. Miller SC, Jee WSS (1990). The bone forming cells: origin, distribution, proliferation and differentiation. In Takahashi H (Ed.), Bone Morphometry (pp. 29-36). Niigata: Nishimura Co., Ltd.
  9. Miller SC, Miller MA (1990). Cancellous bone turnover is increased during lactation in beagles. In Takahashi H (Ed.), Bone Morphometry (pp. 311-3). Niigata: Nishimura Co., Ltd.
  10. Miller SC (1988). Hormonal regulation of osteogenesis. In Davidovitch Z (Ed.), Biological Mechanisms of Tooth Eruption and Root Resorption (pp. 71-9). Ohio State University Press.
  11. Miller SC (1988). Hormonal regulation of osteogenesis. In Davidovitch Z (Ed.), Biological Mechanisms of Tooth Eruption and Root Resorption (pp. 71-9). Ohio State University Press.
  12. Miller SC, Jee WSS, Smith JM, Wronski T (1986). Tissue characteristics of high and low incidence plutonium-induced osteogenic sarcoma sites in life-span beagles. In Thompson RC, Mahaffey JA (Eds.), Lifespan Radiation Effects Studies in Animals: What can they tell us? (83095, pp. 286-98). Washington, DC: USDOE, Office of Scientific and Technical Information.
  13. Wrenn ME, Taylor GN, Stevens W, Mays CW, Jee WSS, Lloyd RD, Atherton DR, Bruenger FW, Kimmel DB, Miller SC, Shabestari L, Smith JM, Woodbury LA, Stover BJ (1986). Summary of dosimetry, pathology, and dose response for bone sarcomas in beagles injected with 226Ra. In Thompson RC, Mahaffey JA (Eds.), Lifespan Radiation Effects Studies in Animals: What can they tell us? (83095, pp. 253-67). Washington, DC: USDOE, Office of Scientific and Technical Information.
  14. Wrenn ME, Taylor GN, Stevens W, Mays CW, Jee WSS, Lloyd RD, Atherton DR, Bruenger FW, Miller SC, Shabestari L, Smith JM, Stover BJ, Woodbury LA (1986). Life-span radiation effects studies in experimental animals at University of Utah Division of Radiobiology. In Thompson RC, Mahaffey JA (Eds.), Lifespan Radiation Effects Studies in Animals: What can they tell us? (83095, pp. 32-52). USDOE, Office of Scientific and Technical Information.
  15. Jee WSS, Parks NJ, Miller SC, Dell RB (1985). Relationship of bone composition to the location of radium-induced bone cancer. In Gossner W, Gerber GB, Hagen U, Luz A (Eds.), The Radiobiology of Radium and Thorotrast (pp. 75-8). Baltimore, MD: Urban and Schwarzenberg.
  16. Jee WSS, Dell RB, Parks NJ, Miller SC, Wrenn ME (1985). Toxicity of plutonium and americium: relationship of bone composition to location of 226Ra, 239Pu and 241Am-induced bone sarcomas. In Priest ND (Ed.), Metals in Bone (pp. 155-74). Hingham, MA: MTP Press Limited.
  17. Paschoa AS, Wrenn ME, Singh NP, Miller SC, Jones KW, Cholewa A, Hanson AL, Saccomanno G (1985). Uranium bearing particles in miners' and millers' lungs. In Stacker H (Ed.), Occupational Radiation Safety in Mining (pp. 511-7). Toronto, Ontario: Canadian Nuclear Association.
  18. Jee WSS, Miller SC, Black HE (1982). The effects of diphosphonates on bone resorption and corticosteroid-induced bone loss. In Donath A, Courvoisier B (Eds.), Diphosphonates and Bone, Symposium CEMO (pp. 132-53). Geneve: Editions Medecine et Hygiene.
  19. Codington JF, Dalianis T, Das HR, Miller SC, Klein G, Jeanloz RS (1982). Cell-surface glycoproteins involved in immunoresistance in tumor cells. In Galeotti T (Ed.), Membranes in Tumour Growth (pp. 163-72). New York, NY: Elsevier Biomedical Press.
  20. Jee WSS, Wronski TJ, Smith JM, Kimmel DB, Miller SC, Stover BJ (1981). Selection of bone samples for Pu239 analyses in man. In Wrenn ME (Ed.), Actinides in Man and Animals (pp. 407-12). Salt Lake City, UT: R. D. Press.

Conference Proceedings

  1. Smith JM, Marshall JH, Miller SC, Jee WSS (1980). Distribution of alpha particle track length within endosteal cell nuclei. New York, NY: Harwood Academic Publishers, 1441-53.

Editorial

  1. Miller SC (2008 Sep). Mini-issue on primary cilia in bone and cartilage: preface to presentations from the Sun Valley Hard Tissue Workshop, August 2007. Utah Special Educator, 291(9), 1047-8.
  2. Miller SC, Jee WS (1987 Jul). The bone lining cell: a distinct phenotype? Calcif Tissue Int, 41(1), 1-5.

Letter

  1. Lloyd RD, Miller SC, Taylor GN, Bruenger FW, Jee WS (2005 Dec). Comments on "Two-mutation models for bone cancer due to radium, strontium and plutonium" by Bijwaard et al. (Radiat. Res. 162, 171-184, 2004) [Letter to the editor]. Radiat Res, 164(6), 828; author reply 828-9.
  2. Lloyd RD, Miller SC, Taylor GN, Bruenger FW, Jee WS (2005 May). Comments about Potter's review of internal dosimetry [Letter to the editor]. Health Phys, 88(5), 497-8; author reply 498.
  3. Lloyd RD, Taylor GN, Miller SC (1993 Oct). Does leukemia result from the presence of radon or thoron in the body? [Letter to the editor]. Health Phys, 65(4), 439-40.

Report

  1. Working Group on the Evaluation of Carcinogenic Risks to Humans Miller SC, member (2001). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 78. Ionizing Radiation, Part 2: Some Internally Deposited Radionuclides. World Health Organization, International Agency for Research on Cancer.
  2. Miller SC Principal Investigator, Slaughter DM, Thompson J, Kenner G, Krahenbuhl MP, Tripp D, Wilde J, Shelky B, Mecham S, Choe D-O, Moeller HF, Griffon M, Bloom C (2000). Exposure Assessment Project at The Paducah Gaseous Diffusion Plant. University of Utah. Salt Lake City, UT: Paper, Allied Industrial, Chemical and Energy Workers (PACE) International, Union and the U.S. Department of Energy, Office of Environment, Safety and Health.
  3. LLoyd RD, Taylor GN, Miller SC (1994). Relationship of leukemia and radon or thoron in the body. Salt Lake City, UT: University of Utah.
  4. Taylor GN, Lloyd RD, Bruenger FW, Miller SC (1994). Thyroid lesions induced by 241Am in the Beagle dog. Salt Lake City, UT: University of Utah.
  5. Lloyd RD, Taylor GN, Angus W, Miller SC, Boecker BB (1994). Skeletal malignancies in Beagle dogs injected with 241Am. Salt Lake City, UT: University of Utah.
  6. Lloyd RD, Angus W, Taylor GN, Thurman GB, Miller SC (1994). Occurrence of metastases in beagle dogs with skeletal malignancies induced by internal irradiation. Salt Lake City, UT: University of Utah.
  7. Lloyd RD, Taylor GN, Angus W, Miller SC, Bruenger FW, Jee WSS (1994). Distribution of skeletal malignancies in beagles injected with 239Pu citrate. Salt Lake City, UT: University of Utah.
  8. Taylor GN, Lloyd RD, Bruenger FW, Miller SC (1992). Thyroid lesions induced by 241Am in the Beagle dog. Salt Lake City, UT: University of Utah.
  9. Lloyd RD, Angus W, Taylor GN, Thurman GB, Miller SC (1992). Occurrence of metastases in Beagle dogs with skeletal malignancies induced by internal irradiation. Salt Lake City, UT: University of Utah.
  10. Lloyd RD, Taylor GN, Angus W, Miller SC, Boecker BB (1992). Skeletal malignancies among beagle dogs injected with 241Am. Salt Lake City, UT: University of Utah.
  11. Miller SC, Jee WSS, Bruenger FW, Lloyd RD, Taylor GN (1991). Overview of osseous tissue findings from the lifespan carcinogenesis studies: from whole animals to molecules. Proceedings of the Joint Bone Radiobiology Workshop, Topical Abstracts, held at Toronto, Canada, July 12 & 13, 1991 (UCD-472-136). Davis, CA: Laboratory for Energy-Related Health Research Institute of Toxicology and Environmental Health, University of California.
  12. Lloyd RD, Taylor GN, Bruenger FW, Angus W, Miller SC (1991). Occurrence of bone cancer among young adult beagles given 239Pu. Proceedings of the Joint Bone Radiobiology Workshop, Topical Abstracts, held at Toronto, Canada (UCD-472-136). Davis, CA: Laboratory for Energy-Related Health Research Institute of Toxicology and Environmental Health, University of California.
  13. Bruenger FW, Miller SC, Lloyd RD (1991). The influence of age at time of exposure to 239Pu or 226Ra on retention, distribution, survival and tumor induction in beagles. Proceedings of the Joint Bone Radiobiology Workshop (UCD-472-136). Davis, CA: Laboratory for Energy-Related Health Research Institute of Toxicology and Environmental Health, University of California.
  14. Miller SC, Jee WSS, Bruenger FW, Lloyd RD, Taylor GN (1991). Overview of osseous tissue findings from the lifespan carcinogenesis studies: From whole animals to molecules. Proceedings of the Joint Bone Radiobiology Workshop (UCD-472-136). Washington, DC: USDOE, Office of Scientific and Technical Information.
  15. Lloyd RD, Taylor GN, Bruenger FW, Angus W, Miller SC (1991). Occurrence of bone cancer among young adult beagles given 239Pu. Proceedings of the Joint Bone Radiobiology Workshop (UCD-472-136). Washington, DC: USDOE, Office of Scientific and Technical Information.
  16. Bruenger FW, Miller SC, Lloyd RD (1991). The influence of age at time of exposure to 239Pu or 226Ra on retention, distribution, survival and tumor induction in Beagles. Proceedings of the Joint Bone Radiobiology Workshop (UCD-472-136). Washington, DC: USDOE, Office of Scientific and Technical Information.
  17. Taylor GN, Lloyd RD, Mays CW, Shabestari L, Miller SC (1991). Promotion of radiation-induced liver neoplasia by ethanol. Salt Lake City, UT: University of Utah.
  18. Bruenger FW, Lloyd RD, Taylor GN, Angus W, Miller SC (1991). Mammary tumors among dogs injected with 226Ra. Salt Lake City, UT: University of Utah.
  19. Lloyd RD, Taylor GN, Angus W, Bruenger FW, Miller SC (1991). Eye tumors and other lesions among beagle dogs given 90Sr or 226Ra. Salt Lake City, UT: University of Utah.
  20. Lloyd RD, Taylor GN, Angus W, Bruenger FW, Miller SC (1990). Bone cancer occurrence among young adult beagles given Pu-239. Salt Lake City, UT: University of Utah.
  21. Lloyd RD, Miller SC, Bruenger FW, Polig E, Jee WSS, Taylor GN, Angus W (1990). Dosimetry of Ra-226 for individual bones of the Beagle dog skeleton. Salt Lake City, UT: University of Utah.
  22. Lloyd RD, Bruenger FW, Miller SC, Angus W, Taylor GN, Jee WSS, Polig E (1990). Distribution of radium-induced skeletal malignancies in dogs and humans. Salt Lake City, UT: University of Utah.
  23. Bruenger FW, Miller SC, Lloyd RD (1990). A comparison of the natural survival of beagle dogs injected intravenously with low levels of 239Pu, 228Th, 226Ra, 228Ra, and 90Sr. Salt Lake City, UT: University of Utah.
  24. Taylor GN, Lloyd RD, Mays CW, Angus W, Miller SC, Hahn FF (1990). Plutonium or americium-induced liver tumors in Beagles. Salt Lake City, UT: University of Utah.
  25. Miller SC, Bruenger FW, Lloyd RD, Jee WSS, Taylor GN (1990). Distribution of skeletal tumors in young adult beagle dogs exposed to 226Ra. University of Utah.
  26. Bruenger FW, Lloyd RD, Miller SC (1990). The influence of age at time of exposure to 226Ra or 239Pu on tumor induction and post-injection survival in beagle dogs. Salt Lake City, UT: University of Utah.
  27. Miller SC, Bruenger FW, Lloyd RD, Jee WSS, Taylor GN (1989). Distribution of skeletal tumors in young adult beagle dogs exposed to 226Ra. University of Utah.
  28. Lloyd RD, Bruenger FW, Tayler GN, Miller SC, Mays CW (1989). Kidney disease among beagles injected with 226Ra and accompanying 210Po. Salt Lake City, UT: University of Utah.
  29. Bruenger FW, Lloyd RD, Miller SC (1989). The influence of age at time of exposure to 226Ra or 239Pu on tumor induction and post-injection survival in beagle dogs. Salt Lake City, UT: University of Utah.
  30. Miller SC, Bruenger FW, Lloyd RD, Jee WSS, Taylor GN (1989). Distribution of skeletal tumors in young adult beagle dogs exposed to 226Ra. Salt Lake City, UT: University of Utah.
  31. Miller SC, Bowman BM, Miller MA (1989). Cancellous bone remodeling during pregnancy in beagle dogs. Salt Lake City, UT: University of Utah.
  32. Lloyd RD, Miller SC, Taylor GN, Bruenger FW, Angus W, Jee WSS (1988). Survial, dosimetry, and skeletal malignancy experience in the beagle 226Ra life-span study at the University of Utah. Salt Lake City, UT: University of Utah.
  33. Miller MA, Omura TH, Miller SC (1987). Changes in bone remodeling during lactation in beagles. Washington, DC: U.S. Department of Commerce.
  34. Bowman BM, Miller SC (1987). Cellular DNA content and tumor antigen analyses in archived radiation-induced tumors. Washington, DC: U.S. Department of Commerce.
  35. Miller SC, Bruenger FW, Williams FW (1986). The retention of 239Pu in beagle gonads. Washington, DC: U.S. Department of Commerce.
  36. Dougan ST, Bowman BM, Miller SC (1985). The comparative distribution of iron and plutonium in the ovary. Washington, DC.: U.S. Department of Commerce.
  37. Miller SC, Bowman BM, Redd EH, Shupe JG, Miller MA, Omura TH, Smith LJ (1985). Skeletal changes during pregnancy and lactation. Washington, DC: U.S. Department of Commerce.
  38. Bowman BM, Miller SC (1985). Osteogenic potential of bone-lining cells in the adult skeleton. Washington, DC: U.S. Department of Commerce.
  39. Wrenn ME, Taylor GN, Stevens W, Mays CW, Jee WSS, Lloyd RD, Atherton DR, Bruenger FW, Kimmel DB, Miller SC, Shabestari L, Smith JM, Stover BJ (1985). Summary of dosimetry, pathology and dose response for bone sarcomas in beagles injected with 228Ra. Res. in Radiobiology. Washington, DC: U.S. Department of Commerce.
  40. Miller SC, Bowman BM, Rowland HG (1984). Distributions of cell populations within alpha particle range of plutonium deposits in the rat and beagle testis. Washington, DC: U.S. Department of Commerce.
  41. Bowman BM, Miller SC (1984). Cell proliferation and differentiation in estrogen-induced medullary bone osteogenesis in adult male Japanese quail. Washington, DC: U.S. Department of Commerce.
  42. Miller SC, Bowman BM, Rowland HG, Roberts LK (1983). Immunologic and phagocytic characteristics of plutonium-incorporating cells isolated from the testis. Washington, DC: U.S. Department of Commerce.
  43. Miller SC, Jee WSS, Smith JM (1983). Tissue characteristics of plutonium-induced osteogenic sarcoma sites in lifespan beagles. Washington, DC: U.S. Department of Commerce.
  44. Wrenn ME, Taylor GN, Stevens W, Mays CW, Jee WSS, Lloyd RD, Atherton DR, Bruenger FW, Kimmel DB, Miller SC, Shabestari L, Smith JM, Stover BJ (1983). Summary of dosimetry, pathology, and dose response for bone sarcomas in beagles injected with 226Ra. Washington, DC: U.S. Department of Commerce.
  45. Miller SC, Bowman BM, Rowland HG (1982). Tissue and cellular distribution of plutonium-241 in rat testes. Washington, DC: U.S. Department of Commerce.
  46. Miller SC, Bowman BM (1982). Expected resolution of plutonium-241 in electron microscope autoradiography. Washington, DC: U.S. Department of Commerce.
  47. Miller SC, Smith JM, Rowland HG, Bowman BM, Jee WSS (1982). The relationship of bone marrow microvasculature with plutonium incorporation into bone. Washington, DC: U.S. Department of Commerce.
  48. Miller SC, Bowman BM, Rowland HG (1980). Comparison of the autoradiographic localization of plutonium in the testes of rats and dogs. Washington, DC: U.S. Department of Commerce.
  49. Miller SC, Bowman BM, Jee WSS (1980). The microvascular bed of fatty bone marrow in the adult beagle: implications for plutonium incorporation and distribution in bone. Washington, DC: U.S. Department of Commerce.
  50. Smith JM, Marshall JH, Miller SC, Jee WSS (1980). Distributions of alpha particle track length within endosteal cell nuclei. Washington, DC: U.S. Department of Commerce.
  51. Miller SC, Bowman BM, Smith JM, Jee WSS (1979). Characterization of bone-surface cells in a fatty-marrow, low turnover-incidence bone site of the beagle. U.S. Department of Commerce.
  52. Miller SC, Kimmel DB, Jee WSS (1978). Histological study of trabecular bone of beagle rib. Washington, DC: U.S. Department of Commerce.
  53. Jee WSS, Smith JM, Kimmel DB, Miller SC, Van Dura C, Smith C (1978). Preliminary surface/volume ratios and bone turnover rates of trabecular bone in young adult beagles. Washington, DC: U.S. Department of Commerce.
  54. Hashimoto EG, Miller SC, Kimmel DB, Jee WSS (1975). A possible model for osteoclast nuclei kinetics. Washington, DC: U.S. Department of Commerce.
  55. Jee WSS, Kimmel DB, Miller SC, Yee YA, Woodbury LA, Dell R (1974). Plutonium, diphosphonates and bone. Washington, DC: U.S. Department of Commerce.
  56. Miller SC, Jee WSS, Smith JM (1973). The effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) and disodium dichloromethanediphosphonate (Cl2MDP) on bone of the proximal tibia of the growing rat. Washington, DC: U.S. Department of Commerce.